[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @KontraInvest Kontra Kontra posts on X about $nvo, $lly, gain, trx the most. They currently have XXXXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::131843346/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX +263% - X Year XXXXXXX +224% ### Mentions: X [#](/creator/twitter::131843346/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XXX +17% - X Year XXX +24% ### Followers: XXXXX [#](/creator/twitter::131843346/followers)  - X Week XXXXX +0.39% - X Month XXXXX +1.90% - X Months XXXXX +13% - X Year XXXXX +9.40% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::131843346/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXXX% [finance](/list/finance) XXXXX% [currencies](/list/currencies) XXXXX% **Social topic influence** [$nvo](/topic/$nvo) 22.22%, [$lly](/topic/$lly) 11.11%, [gain](/topic/gain) 11.11%, [trx](/topic/trx) 11.11%, [nvo](/topic/nvo) 11.11%, [$teva](/topic/$teva) 11.11%, [debt](/topic/debt) 11.11%, [emerging markets](/topic/emerging-markets) 11.11%, [math](/topic/math) 11.11%, [eps](/topic/eps) XXXXX% **Top accounts mentioned or mentioned by** [@investspecial](/creator/undefined) [@researchpulse1](/creator/undefined) [@jcannush](/creator/undefined) **Top assets mentioned** [Novo-Nordisk (NVO)](/topic/$nvo) [Eli Lilly and Company (LLY)](/topic/$lly) [Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)](/topic/$teva) ### Top Social Posts Top posts by engagements in the last XX hours "Some good information here on $NVO and $LLY" [X Link](https://x.com/KontraInvest/status/1995629402806518230) 2025-12-01T23:01Z 1807 followers, XXX engagements "A good day to re-post this $TEVA" [X Link](https://x.com/KontraInvest/status/1993690871099715996) 2025-11-26T14:38Z 1807 followers, XXX engagements "The market is pricing a funeral for a duopoly king $NVO Everyone is chasing Lilly at 35x earnings while leaving Novo Nordisk for dead at 13x. I get it. The 2026 narrative is ugly. We have patent cliffs in emerging markets "Most-Favored-Nation" pricing cuts in the US and a projected EPS drop of 7%. The chart looks like a crime scene. But lets look at the implied math. At XXX DKK the market is pricing in a -XXXX% annual revenue declinefor the next five years. For a company with a functional duopoly in the biggest health trend of the century That is capitulation math. Im not ignoring the" [X Link](https://x.com/KontraInvest/status/1997770320527127006) 2025-12-07T20:48Z 1807 followers, 2009 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@KontraInvest KontraKontra posts on X about $nvo, $lly, gain, trx the most. They currently have XXXXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXXX% currencies XXXXX%
Social topic influence $nvo 22.22%, $lly 11.11%, gain 11.11%, trx 11.11%, nvo 11.11%, $teva 11.11%, debt 11.11%, emerging markets 11.11%, math 11.11%, eps XXXXX%
Top accounts mentioned or mentioned by @investspecial @researchpulse1 @jcannush
Top assets mentioned Novo-Nordisk (NVO) Eli Lilly and Company (LLY) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)
Top posts by engagements in the last XX hours
"Some good information here on $NVO and $LLY"
X Link 2025-12-01T23:01Z 1807 followers, XXX engagements
"A good day to re-post this $TEVA"
X Link 2025-11-26T14:38Z 1807 followers, XXX engagements
"The market is pricing a funeral for a duopoly king $NVO Everyone is chasing Lilly at 35x earnings while leaving Novo Nordisk for dead at 13x. I get it. The 2026 narrative is ugly. We have patent cliffs in emerging markets "Most-Favored-Nation" pricing cuts in the US and a projected EPS drop of 7%. The chart looks like a crime scene. But lets look at the implied math. At XXX DKK the market is pricing in a -XXXX% annual revenue declinefor the next five years. For a company with a functional duopoly in the biggest health trend of the century That is capitulation math. Im not ignoring the"
X Link 2025-12-07T20:48Z 1807 followers, 2009 engagements
/creator/twitter::KontraInvest